Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Microbot Medical Inc (MBOT)

Microbot Medical Inc (MBOT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Microbot Medical Inc 175 DERBY ST. BLD. 27 HINGHAM MA 2043 USA

www.microbotmedical.com Employees: 21 P: 781-875-3605 F: 781-556-5347

Sector:

Medical

Description:

Microbot Medical Inc. is engaged in the research, design, development and commercialization of micro-robotics assisted medical technologies. Its product candidate includes the Self Cleaning Shunt for the treatment of hydrocephalus and Normal Pressure Hydrocephalus and TipCAT, a self-propelling, semi-disposable endoscope which is being developed initially for use in colonoscopy procedures. Microbot Medical Inc., formerly known as Stemcells, Inc., is headquartered in Hingham, MA.

Key Statistics

Overview:

Market Capitalization, $K 141,703
Enterprise Value, $K 138,543
Shares Outstanding, K 67,158
Annual Sales, $ 0 K
Annual Net Income, $ -11,440 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,580 K
EBIT, $ -14,030 K
EBITDA, $ -13,940 K
60-Month Beta 1.23
% of Insider Shareholders 4.74%
% of Institutional Shareholders 16.30%
Float, K 63,975
% Float 95.26%
Short Interest 6,424
Short Float 9.56%
Short Volume Ratio 0.58

Growth:

1-Year Return -26.09%
3-Year Return -43.05%
5-Year Return -73.74%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 57.06%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.07 on 11/12/25
Next Earnings Date 03/24/26
Earnings Per Share ttm -0.45
EPS Growth vs. Prev Qtr 30.00%
EPS Growth vs. Prev Year 65.00%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-15 on 09/05/18

MBOT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -37.06%
Return-on-Assets % -34.44%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.72
Book Value/Share 1.16
Interest Coverage -1.29
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar